Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,223
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Tran, K. B., Lang, J. J., Compton, K., Xu, R., Acheson, A. R., Henrikson, H. J., Kocarnik, J. M., Penberthy, L., Aali, A., Abbas, Q., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01438-6 · Cited by 954
Pathobiology of Helicobacter pylori–Induced Gastric Cancer
Amieva, M., & Peek, R. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.09.004 · Cited by 895
Self-citationNF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 776
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
“Non-viral infectious causes for human cancer are reviewed elsewher”
BackgroundThe immune system and the gut microbiota: friends or foes?
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010) · Nature Reviews Immunology · doi:10.1038/nri2850 · Cited by 704
“The circumstances that lead to this bacterium becoming a serious health concern are not completely understood but are thought to include the selection of specifically aggressive strains and/or host predisposing factors, notably polymorphisms in gene promoters that increase the production of tumour necrosis factor (TNF…”
BackgroundThe oral microbiota in colorectal cancer is distinctive and predictive
Flemer, B., Warren, R. D., Barrett, M. P., Cisek, K., Das, A., Jeffery, I. B., Hurley, E., O‘Riordain, M., Shanahan, F., & O‘Toole, P. W. (2018) · Gut · doi:10.1136/gutjnl-2017-314814 · Cited by 646
Gut Microbiota, Inflammation, and Colorectal Cancer
Brennan, C. A., & Garrett, W. S. (2016) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095513 · Cited by 578
“Despite the seemingly insurmountable selective pressures exerted by evolving tumors, the concept of microbe-driven cancer is longstanding, given the well-described roles of Helicobacter pylori in gastric cancer (70) and human papillomavirus in cervical cancer (13), among others (Figure 1).”
BackgroundSundar, R., Nakayama, I., Markar, S. R., Shitara, K., van Laarhoven, H. W. M., Janjigian, Y. Y., & Smyth, E. C. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00052-2 · Cited by 393
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Chow, J., Tang, H., & Mazmanian, S. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.010 · Cited by 448
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Dohlman, A. B., Klug, J., Mesko, M., Gao, I. H., Lipkin, S. M., Shen, X., & Iliev, I. D. (2022) · Cell · doi:10.1016/j.cell.2022.09.015 · Cited by 413
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Mirzaei, R., Afaghi, A., Babakhani, S., Sohrabi, M. R., Hosseini-Fard, S. R., Babolhavaeji, K., Khani Ali Akbari, S., Yousefimashouf, R., & Karampoor, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111619 · Cited by 394
Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.010 · Cited by 411
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
Gambardella, V., Castillo, J., Tarazona, N., Gimeno-Valiente, F., Martínez-Ciarpaglini, C., Cabeza-Segura, M., Roselló, S., Roda, D., Huerta, M., Cervantes, A., et al. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102015 · Cited by 335
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
“One of the key steps in the histologic progression to intestinal-type gastric cancer is atrophy, which is accompanied by an increase in gastric pH as a result of loss of parietal cells.(4) Within the context of atrophic gastritis, nonmolecular analyses have shown that, in the absence of H pylori, urease-producing memb…”
BackgroundSelf-citationThe Human Microbiome and Cancer
Rajagopala, S. V., Vashee, S., Oldfield, L. M., Suzuki, Y., Venter, J. C., Telenti, A., & Nelson, K. E. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0249 · Cited by 303
Evidence‐based Guidelines From ESPGHAN and NASPGHAN for Helicobacter pylori Infection in Children
Koletzko, S., Jones, N. L., Goodman, K. J., Gold, B., Rowland, M., Cadranel, S., Chong, S., Colletti, R. B., Casswall, T., Elitsur, Y., et al. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182227e90 · Cited by 309
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
Eun, C. S., Kim, B. K., Han, D. S., Kim, S. Y., Kim, K. M., Choi, B. Y., Song, K. S., Kim, Y. S., & Kim, J. F. (2014) · Helicobacter · doi:10.1111/hel.12145 · Cited by 292
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
Salvatori, S., Marafini, I., Laudisi, F., Monteleone, G., & Stolfi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032895 · Cited by 252
“pylori infection are asymptomatic, all will sooner or later develop gastritis which, in the long run, may result in the emergence of gastroduodenal ulcers and eventually gastric carcinoma and lymphoma of the lymphoid tissue associated with the mucosa [4].”
BackgroundChang, M. X., & Xiong, F. (2020) · Molecules · doi:10.3390/molecules25225342 · Cited by 268
“Infection with Helicobacter pylori is a critical cause of gastrointestinal diseases, which stimulates the production of ROS and leads to the expression of inflammatory mediators in tissues [77].”
Background2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment
Zhou, L., Lu, H., Song, Z., Lyu, B., Chen, Y., Wang, J., Xia, J., Zhao, Z., & on behalf of Helicobacter Pylori Study Group of Chinese Society of Gastroenterology (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002546 · Cited by 249
“It is a major cause for indigestion, gastritis, peptic ulcer, and gastric cancer,([4]) and is the second most common cause for cancer death in the world with 783,000 reported deaths in 2018 alone.”
BackgroundScanu, T., Spaapen, R. M., Bakker, J. M., Pratap, C. B., Wu, L.-E., Hofland, I., Broeks, A., Shukla, V. K., Kumar, M., Janssen, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.002 · Cited by 266
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Kaczmarek, M., Poznańska, J., Fechner, F., Michalska, N., Paszkowska, S., Napierała, A., & Mackiewicz, A. (2023) · Cells · doi:10.3390/cells12172159 · Cited by 241
“Among the well-known examples is Helicobacter pylori, which is strongly associated with gastric cancer [68].”
BackgroundEngineered Cementitious Composites (ECC) Material, Structural, and Durability Performance
Li, V. C. (2008) · Deep Blue (University of Michigan) · Cited by 343
The Role of CRISPR-Cas Systems in Virulence of Pathogenic Bacteria
Louwen, R., Staals, R. H. J., Endtz, H. P., van Baarlen, P., & van der Oost, J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00039-13 · Cited by 247
Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma
Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I., & Cha, S. (2011) · International Journal of Oral Science · doi:10.4248/ijos11075 · Cited by 245
Raju, D., Hussey, S., Ang, M., Terebiznik, M. R., Sibony, M., Galindo–Mata, E., Gupta, V., Blanke, S. R., Delgado, A., Romero–Gallo, J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.043 · Cited by 245
Self-citationMueller, D., Tegtmeyer, N., Brandt, S., Yamaoka, Y., De Poire, E., Sgouras, D., Wessler, S., Torres, J., Smolka, A., & Backert, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61143 · Cited by 239
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Bou Kheir, T., Futoma-Kazmierczak, E., Jacobsen, A., Krogh, A., Bardram, L., Hother, C., Grønbæk, K., Federspiel, B., Lund, A. H., & Friis-Hansen, L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-29 · Cited by 240
“Pylori infected persons develop tumours [3].”
Yong, X., Tang, B., Li, B.-S., Xie, R., Hu, C.-J., Luo, G., Qin, Y., Dong, H., & Yang, S.-M. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0111-0 · Cited by 235
Obesity and cancer pathogenesis
Berger, N. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12416 · Cited by 231
Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis
Hathroubi, S., Servetas, S. L., Windham, I., Merrell, D. S., & Ottemann, K. M. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-18 · Cited by 227
“pylori as one of the most prevalent global pathogens as well as the most common bacterial infection (9).”
BackgroundHelicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression
Díaz, P., Valenzuela Valderrama, M., Bravo, J., & Quest, A. F. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00005 · Cited by 226
“…bacterial factors including, but not limited to, urease, vacuolating cytotoxin A (VacA), cag pathogenicity island, cytotoxin-associated gene A (CagA), peptidoglycan outer membrane proteins (e.g., BabA, SabA, OipA), and γ-glutamyl transpeptidase (GGT) (Polk and Peek, 2010; Valenzuela et al., 2013).”
BackgroundInfluentialHennequin, A., Derangère, V., Boidot, R., Apetoh, L., Vincent, J., Orry, D., Fraisse, J., Causeret, S., Martin, F., Arnould, L., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1054598 · Cited by 226
“A particularity of gastric cancer is the Helicobacter pylori-induced chronic gastritis, which constitutes a major risk factor of gastric cancer.(6) Due to the related persistent inflammatory response and expression of tumor-associated antigens, as well as antigens produced by the H.”
BackgroundH. pylori infection and gastric cancer: State of the art
CONTEDUCA, V., SANSONNO, D., LAULETTA, G., RUSSI, S., INGRAVALLO, G., & DAMMACCO, F. (2013) · International Journal of Oncology · doi:10.3892/ijo.2012.1701 · Cited by 231
Bacterial infections and cancer
van Elsland, D., & Neefjes, J. (2018) · EMBO reports · doi:10.15252/embr.201846632 · Cited by 213
“pylori activates EGFR (epidermal growth factor receptor) and stimulates Akt and b-catenin signalling, a phenotype observed in a number of different cancers, including gastric cancer (Fig 1B) [34,35].”
Mamun, T. I., Younus, S., & Rahman, M. H. (2024) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2024.100845 · Cited by 248
Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies
Ali, A., & AlHussaini, K. I. (2024) · Microorganisms · doi:10.3390/microorganisms12010222 · Cited by 162
“Such an effective diagnosis and eradication can further prevent the progression of gastric carcinogenesis and also has the potential to reverse unregulated cell growth [91].”
miRNAs reshape immunity and inflammatory responses in bacterial infection
Zhou, X., Li, X., & Wu, M. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0006-9 · Cited by 182
Helicobacter pylori Infection and Gastric Adenocarcinoma.
Correa, P., & Piazuelo, M. B. (2011) · PubMed · Cited by 235
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., & Gorvel, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.171 · Cited by 189
Understanding the role of the gut microbiome in gastrointestinal cancer: A review
Ağagündüz, D., Cocozza, E., Cemali, Ö., Bayazıt, A. D., Nanì, M. F., Cerqua, I., Morgillo, F., Saygılı, S. K., Berni Canani, R., Amero, P., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1130562 · Cited by 189
Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes
Gullo, I., Grillo, F., Mastracci, L., Vanoli, A., Carneiro, F., Saragoni, L., Limarzi, F., Ferro, J., Parente, P., & Fassan, M. (2020) · Pathologica · doi:10.32074/1591-951x-166 · Cited by 177
Chlamydia Infection Promotes Host DNA Damage and Proliferation but Impairs the DNA Damage Response
Chumduri, C., Gurumurthy, R. K., Zadora, P. K., Mi, Y., & Meyer, T. F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.010 · Cited by 174
Genetic variation and gastric cancer risk: a field synopsis and meta-analysis
Mocellin, S., Verdi, D., Pooley, K. A., & Nitti, D. (2015) · Gut · doi:10.1136/gutjnl-2015-309168 · Cited by 181
Backert, S., Clyne, M., & Tegtmeyer, N. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-28 · Cited by 174
Mapping the genomic diaspora of gastric cancer
Yeoh, K. G., & Tan, P. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00412-7 · Cited by 169
Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
Noto, J. M., Gaddy, J. A., Lee, J. Y., Piazuelo, M. B., Friedman, D. B., Colvin, D. C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64373 · Cited by 178
“pylori strains that harbor the cag pathogenicity island induce more severe gastric injury and further augment the risk for developing cancer of the stomach (1).”
Self-citationBacteria and tumours: causative agents or opportunistic inhabitants?
Cummins, J., & Tangney, M. (2013) · Infectious Agents and Cancer · doi:10.1186/1750-9378-8-11 · Cited by 178
“In other cases, the development of cancer is indirect, such as with Helicobacter pylori, which contributes to both gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma due to chronic inflammation caused by the bacteria [3,4].”
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Medicinal plant activity onHelicobacter pylorirelated diseases
Wang, Y.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10368 · Cited by 198
Qiao, H., Tan, X.-R., Li, H., Li, J.-Y., Chen, X.-Z., Li, Y.-Q., Li, W.-F., Tang, L.-L., Zhou, G.-Q., Zhang, Y., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2810 · Cited by 168
“<45 125 107 (55) 18 (38) 112 85 (46) 27 (54) 87 64 (39) 23 (34)”
AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes
Gawron, A. J., Shah, S. C., Altayar, O., Davitkov, P., Morgan, D., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.001 · Cited by 175
E-Cadherin and Gastric Cancer: Cause, Consequence, and Applications
Liu, X., & Chu, K. (2014) · BioMed Research International · doi:10.1155/2014/637308 · Cited by 190
“pylori infection is the strongest risk factor for gastric cancer development [57, 58].”
BackgroundSurvival in hostile territory: the microbiota of the stomach
Yang, I., Nell, S., & Suerbaum, S. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12027 · Cited by 163
Rihawi, K., Ricci, A. D., Rizzo, A., Brocchi, S., Marasco, G., Pastore, L. V., Llimpe, F. L. R., Golfieri, R., & Renzulli, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083805 · Cited by 166
“In GC, chronic inflammation of the gastric mucosa caused by HP infection has been established as an important risk factor in the development of the tumor, causing immune cell migration to the stomach and the production of chemokines and cytokines, which will eventually lead to the activation of survival signaling path…”
BackgroundGonzález, C. A., & Agudo, A. (2012) · International Journal of Cancer · doi:10.1002/ijc.26430 · Cited by 160
Mukherjee, S., Patra, R., Behzadi, P., Masotti, A., Paolini, A., & Sarshar, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244345 · Cited by 166
Smith, S. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9912 · Cited by 159
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
Zhou, B., Sun, C., Huang, J., Xia, M., Guo, E., Li, N., Lu, H., Shan, W., Wu, Y., Li, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-38031-2 · Cited by 145
Helicobacter pylori Causes Epigenetic Dysregulation of FOXD3 to Promote Gastric Carcinogenesis
Cheng, A. S. L., Li, M. S. M., Kang, W., Cheng, V. Y. Y., Chou, J., Lau, S. S., Go, M. Y. Y., Lee, C. C., Ling, T. K. �., Ng, E. K. O., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.002 · Cited by 152
Accumulation of Somatic Mutations in TP53 in Gastric Epithelium With Helicobacter pylori Infection
Shimizu, T., Marusawa, H., Matsumoto, Y. M., Inuzuka, T., Ikeda, A., Fujii, Y., Minamiguchi, S., Miyamoto, S., Kou, T., Sakai, Y., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.036 · Cited by 161
Lee, J., Roberts, J. S., Atanasova, K. R., Chowdhury, N., Han, K., & Yilmaz, Ö. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00493 · Cited by 142
Morgan, E. L., & Macdonald, A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007835 · Cited by 158
Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects
Öztekin, M., Yılmaz, B., Ağagündüz, D., & Capasso, R. (2021) · Diseases · doi:10.3390/diseases9040066 · Cited by 178
“pylori and bacterial factors, including urease, VacA, CagA, and peptidoglycan outer membrane proteins (BabA, OipA, SabA), affect gastric epithelial cells [68].”
BackgroundExosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA
Shimoda, A., Ueda, K., Nishiumi, S., Murata‐Kamiya, N., Mukai, S., Sawada, S., Azuma, T., Hatakeyama, M., & Akiyoshi, K. (2016) · Scientific Reports · doi:10.1038/srep18346 · Cited by 148
The inflammatory inception of gallbladder cancer
Espinoza, J. A., Bizama, C., García, P., Ferreccio, C., Javle, M. M., Miquel, J. F., Koshiol, J. E., & Roa, J. C. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.004 · Cited by 158
“The best evidence for causal bacterial involvement in inflammation-induced cancer comes from infections with Helicobacter pylori, a known risk factor for gastric adenocarcinoma [128].”
Nejati, S., Karkhah, A., Darvish, H., Validi, M., Ebrahimpour, S., & Nouri, H. R. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.016 · Cited by 169
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)
Porras, C., Nodora, J., Sexton, R., Catterina Ferreccio, R., Jiménez, S., Domínguez, R. L., Cook, P., Anderson, G. L., Morgan, D. R., Baker, L. H., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0117-5 · Cited by 172
Wroblewski, L. E., Piazuelo, M. B., Chaturvedi, R., Schumacher, M., Aihara, E., Feng, R., Noto, J. M., Delgado, A., Israel, D. A., Zavros, Y., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307650 · Cited by 143
Self-citationXiao, H., Zhang, Y., Kim, Y., Kim, S. H., Kim, J. J., Kim, K. M., Yoshizawa, J., Fan, L.-Y., Cao, C., & Wong, D. T. (2016) · Scientific Reports · doi:10.1038/srep22165 · Cited by 142
Probiotic Lactobacillus spp. Act Against Helicobacter pylori-induced Inflammation
Chen, Y.-H., Tsai, W.-H., Wu, H.-Y., Chun-ya, C., Yeh, W.-L., Chen, Y.-H., Hsu, H.-Y., Chen, W., Chen, Y., Chang, W., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010090 · Cited by 141
“This infection is associated with atrophic gastritis [3] and gastric cancer [4,5], thus suggesting that eradication of H.”
BackgroundThe role of inflammation in the pathogenesis of lung cancer
Cho, W. C., Kwan, C. K., Yau, S., So, P. P., Poon, P. C., & Au, J. S. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.599801 · Cited by 122
“liver [9], stomach [10] and prostate [11] are also attributed to chronic inflammation or persistent infection [12].”
BackgroundHu, Y.-L., Pang, W., Huang, Y., Zhang, Y., & Zhang, C. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00433 · Cited by 143
Helicobacter pylori in gastric carcinogenesis
Ahn, H. J., & Lee, D. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i12.455 · Cited by 139
Multifunctional theranostic applications of biocompatible green-synthesized colloidal nanoparticles
Ovais, M., Khalil, A. T., Raza, A., Islam, N. U., Ayaz, M., Saravanan, M., Ali, M., Ahmad, I., Shahid, M. M., & Shinwari, Z. K. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8928-2 · Cited by 137
Helicobacter pylori infection: Host immune response, implications on gene expression and microRNAs
Cadamuro, A. C. T., Rossi, A. F. T., Maniezzo, N. M., & Silva, A. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i6.1424 · Cited by 135
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 140
“These include the predisposition of patients with Crohn's disease to colorectal cancer [83], Helicobacter pylori infection to gastric cancer [84], and human papillomavirus (HPV) infection to cervical cancer [85] and head and neck carcinoma [86, 87].”
BackgroundBure, I. V., Nemtsova, M. V., & Zaletaev, D. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122870 · Cited by 138
“pylori infection modulates the promoter methylation status of tumor suppressor genes, including CDH1, during GC development and progression [56].”
BackgroundShirani, M., Pakzad, R., Haddadi, M. H., Akrami, S., Asadi, A., Kazemian, H., Moradi, M., Kaviar, V. H., Zomorodi, A. R., Khoshnood, S., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08504-5 · Cited by 133
“Epidemiologic and clinical data have demonstrated the role of H. pylori in up to 75% of non-cardia gastric malignancies and up to 98% of gastric cardia malignancies [4].”
BackgroundVarga, M. G., Shaffer, C. L., Sierra, J. C., Suárez, G., Piazuelo, M. B., Whitaker, M. E., Romero–Gallo, J., Krishna, U. S., Delgado, A., Zuleta, M. A. G., et al. (2016) · Oncogene · doi:10.1038/onc.2016.158 · Cited by 132
Self-citationCell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
Hassan, N., Greve, B., Espinoza‐Sánchez, N. A., & Götte, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109822 · Cited by 135
Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo
Johnson, K. S., & Ottemann, K. M. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.019 · Cited by 143
Ansari, S., & Yamaoka, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197430 · Cited by 137
Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression
Hsu, K., Hsieh, R., Huang, K., Li, A. F., Chi, C., Wang, T.-Y., Tseng, M.-J., Wu, K.-J., & Yeh, T.-S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs165 · Cited by 127
Epigenetic modifications of the immune system in health and disease
Obata, Y., Furusawa, Y., & Hase, K. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.114 · Cited by 134
Binder, M., Roberts, C. A., Spencer, N., Antoine, D., & Cartwright, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090924 · Cited by 142
“The link between gastrointestinal cancer and infection by helicobacter pylori, which is recognized to have affected human populations since prehistory [85] is also well established [86].”
BackgroundIntoxication strategy of Helicobacter pylori VacA toxin
Boquet, P., & Ricci, V. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.01.008 · Cited by 138
Gastric Microbiome and Gastric Cancer
Brawner, K. M., Morrow, C. D., & Smith, P. D. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000043 · Cited by 126
“An extremely aggressive malignancy, gastric cancer has a 5-year survival rate in the United States of less than 15%.(1) Gastric cancer is classified into the less common diffuse type and the more common intestinal type.”
BackgroundSalmonella Infection in Chronic Inflammation and Gastrointestinal Cancer
Zha, L., Garrett, S., & Sun, J. (2019) · Diseases · doi:10.3390/diseases7010028 · Cited by 130
“The most widely accepted example of this is that Helicobacter pylori infections can contribute to gastric cancer [92].”
BackgroundA Review of Cancer in U.S. Hispanic Populations
Haile, R. W., John, E. M., Levine, A. J., Cortessis, V. K., Unger, J. B., Gonzales, M., Ziv, E., Thompson, P. A., Spruijt‐Metz, D., Tucker, K. L., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0447 · Cited by 127
Role of Toll-like receptors in Helicobacter pylori infection and immunity
Smith, S. M. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i3.133 · Cited by 131
Bauer, B., & Meyer, T. F. (2011) · Ulcers · doi:10.1155/2011/340157 · Cited by 134
“It consists of individually infiltrating neoplastic cells that do not form glandular structures and are not associated with intestinal metaplasia [94].”
Background
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.